GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hyperfine Inc (NAS:HYPR) » Definitions » Revenue per Share

Hyperfine (Hyperfine) Revenue per Share : $0.16 (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hyperfine Revenue per Share?

Hyperfine's revenue per share for the three months ended in Mar. 2024 was $0.05. Hyperfine's revenue per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.16.

During the past 12 months, the average Revenue Per Share Growth Rate of Hyperfine was 45.50% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 238.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Hyperfine's Revenue per Share or its related term are showing as below:

HYPR' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 238.4   Med: 238.4   Max: 238.4
Current: 238.4

During the past 5 years, Hyperfine's highest 3-Year average Revenue Per Share Growth Rate was 238.40% per year. The lowest was 238.40% per year. And the median was 238.40% per year.

HYPR's 3-Year Revenue Growth Rate is ranked better than
98.93% of 748 companies
in the Medical Devices & Instruments industry
Industry Median: 7.15 vs HYPR: 238.40

Hyperfine Revenue per Share Historical Data

The historical data trend for Hyperfine's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyperfine Revenue per Share Chart

Hyperfine Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Revenue per Share
- - 0.41 0.10 0.16

Hyperfine Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.05 0.03 0.04 0.05

Competitive Comparison of Hyperfine's Revenue per Share

For the Medical Devices subindustry, Hyperfine's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hyperfine's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hyperfine's PS Ratio distribution charts can be found below:

* The bar in red indicates where Hyperfine's PS Ratio falls into.



Hyperfine Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Hyperfine's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )=Revenue (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=11.032/71.316
=0.15

Hyperfine's Revenue Per Share for the quarter that ended in Mar. 2024 is calculated as

Revenue Per Share (Q: Mar. 2024 )=Revenue (Q: Mar. 2024 )/Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
=3.295/71.934
=0.05

Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hyperfine  (NAS:HYPR) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Hyperfine Revenue per Share Related Terms

Thank you for viewing the detailed overview of Hyperfine's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyperfine (Hyperfine) Business Description

Traded in Other Exchanges
N/A
Address
351 New Whitfield Street, Guilford, CT, USA, 06437
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. Legacy Hyperfine and Liminal represent two operating segments of the company. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
Executives
Thomas Teisseyre officer: Chief Operating Officer C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437
Khan Siddiqui officer: See Remarks 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Brett Hale officer: Chief Administrative Officer C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437
Maria Sainz director C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Jonathan M Rothberg director, 10 percent owner C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437
Alok Gupta officer: Chief Financial Officer 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Neela Paykel officer: Gen Counsel & Corp Secretary 530 OLD WHITFIELD STREET, GUILFORD CT 06437
David D Scott director, officer: President and CEO 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Ruth A Fattori director 1303 EAST ALGONQUIN ROAD, SCHAUMBURG IL 60196
Hc Sponsor Llc 10 percent owner 31 HUDSON YARDS, 10TH FLOOR, 28TH FLOOR, NEW YORK NY 10001
Arthur Bruce Cohen 10 percent owner 12 SOUTH MAIN STREET, SUITE #203, NORWALK CT 06854
Healthcor Group, Llc 10 percent owner 31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001
Joseph Patrick Healey 10 percent owner 31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001
R Scott Huennekens director C/O VOLCANO CORPORATION, 11455 EL CAMINO REAL, SUITE 460, SAN DIEGO CA 92130
Scott A. White officer: Chief Commercial Officer 530 OLD WHITFIELD STREET, GUILFORD CT 06437

Hyperfine (Hyperfine) Headlines